The TKI participates in the Marie Curie Initial Training Network (ITN) nEUROinflammation funded by the European Commission Seventh Framework Programme (FP7) for Research and Technological Development. This network combines research in stroke and multiple sclerosis to find strategies to modulate myeloid cell behaviour in the brain for therapeutic purposes. This includes the blood-brain barrier (BBB) as the gate-keeper that controls the invasion of myeloid cells.
The TKI participates by studying the role of blood-brain barrier tight junction proteins in neuroinflammation (Project 5).
The early stage researcher involved in the project was Mariana Dias in the group of Britta Engelhardt.
